Prognostic factors affecting ALS progression through disease tollgates.

Area of Science:

• Neurology
• Clinical Research
• Biostatistics

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease.
• Predicting the timing of critical clinical events in ALS is crucial for patient management.
• Existing models may not fully capture the complex progression trajectories.

Purpose of the Study:

• To identify and understand factors influencing the timing of critical clinical events (tollgates) in ALS progression.
• To develop a more nuanced understanding of ALS disease trajectories.

Main Methods:

• Utilized data from 6366 patients in the PRO-ACT database.
• Augmented patient data with classification of tollgate-passed information.
• Employed Kaplan-Meier analyses for time trajectories and log-rank tests for prognostic factors.
• Used decision-tree classification to identify ALS phenotypes based on initial body segment involvement.

Main Results:

• Both standard factors (gender, onset type) and tollgate-related factors (phenotype, initial tollgate level) significantly impact ALS progression timing.
• Phenotype and initial impairment level demonstrated a stronger effect on progression than standard factors.
• Specific examples illustrate the differential impact, such as bulbar-onset patients progressing faster than limb-onset patients.

Conclusions:

• Tollgate- and phenotype-related factors are key determinants of ALS progression speed.
• A comprehensive consideration of all identified factors is necessary for accurate patient stratification and prediction of disease aggressiveness.